Etoposide and cisplatin versus irinotecan and cisplatin in patients with limited-stage small-cell lung cancer treated with etoposide and cisplatin plus concurrent accelerated hyperfractionated thoracic radiotherapy (JCOG0202): a randomised phase 3 s

Etoposide and cisplatin versus irinotecan and cisplatin in patients with limited-stage small-cell lung cancer treated with etoposide and cisplatin plus concurrent accelerated hyperfractionated thoracic radiotherapy (JCOG0202): a randomised phase 3 s

Item
http://www.wikidata.org/entity/Q33411909
Update in Lung Cancer 2014Highlights for ESMO 40: celebration review for lifetime achievement awardsImpact of thoracic radiotherapy timing in limited-stage small-cell lung cancer: usefulness of the individual patient data meta-analysis.A meta-analysis of randomized controlled trials comparing early and late concurrent thoracic radiotherapy with etoposide and cisplatin/carboplatin chemotherapy for limited-disease small-cell lung cancer.Feasibility study of chemoradiotherapy followed by amrubicin and cisplatin for limited-disease small cell lung cancerPhase I/II study of induction chemotherapy using carboplatin plus irinotecan and sequential thoracic radiotherapy (TRT) for elderly patients with limited-disease small-cell lung cancer (LD-SCLC): TORG 0604Use and misuse of common terminology criteria for adverse events in cancer clinical trials.Advances in pharmacotherapy of small cell lung cancer.The prognostic nutritional index (PNI) predicts overall survival of small-cell lung cancer patients.Prognostic role of patient gender in limited-disease small-cell lung cancer treated with chemoradiotherapy.Randomized phase II trial comparing twice daily hyperfractionated with once daily hypofractionated thoracic radiotherapy in limited disease small cell lung cancer.Effect of sequential chemoradiotherapy in patients with limited-disease small-cell lung cancer who were ineligible for concurrent therapy: a retrospective study at two institutions.Efficacy of prophylactic cranial irradiation in patients with limited-disease small-cell lung cancer who were confirmed to have no brain metastasis via magnetic resonance imaging after initial chemoradiotherapy.Impact of coexistent chronic obstructive pulmonary disease on the survival of patients with small cell lung cancer receiving chemotherapyLow pre-treatment nutritional index is significantly related to poor outcomes in small cell lung cancer
P2860

Etoposide and cisplatin versus irinotecan and cisplatin in patients with limited-stage small-cell lung cancer treated with etoposide and cisplatin plus concurrent accelerated hyperfractionated thoracic radiotherapy (JCOG0202): a randomised phase 3 s

Item
http://www.wikidata.org/entity/Q33411909
description
2013 nî lūn-bûn
@nan
2013 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Etoposide and cisplatin versus ...... G0202): a randomised phase 3 s
@ast
Etoposide and cisplatin versus ...... G0202): a randomised phase 3 s
@en
type
label
Etoposide and cisplatin versus ...... G0202): a randomised phase 3 s
@ast
Etoposide and cisplatin versus ...... G0202): a randomised phase 3 s
@en
prefLabel
Etoposide and cisplatin versus ...... G0202): a randomised phase 3 s
@ast
Etoposide and cisplatin versus ...... G0202): a randomised phase 3 s
@en
P1433
P1476
P2093
P304
P31
P356
P433
P478
P577
P698
P356
P1433
P1476
Etoposide and cisplatin versus ...... G0202): a randomised phase 3 s
@en
P2093
P304
P31
P356
10.1016/S1470-2045(13)70511-4
P433
P478
P577
P698